Autism Diagnoses Prove Highly Stable as Early as 14 Months

Finding suggests earlier, effective identification can result in earlier, more effective treatment

April 29, 2019  |  

Diagnoses of autism spectrum disorder (ASD) by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine in a study published online April 29, 2019 in JAMA Pediatrics.

Growing evidence suggests ASD has its origins in prenatal life — most likely during the first or second trimester of pregnancy — and children begin to display symptoms of the condition by their first birthdays, such as failing to respond to their names or positively interact with others.

Early diagnosis of ASD means earlier intervention and improved therapeutic benefit. “The sooner you can address issues of ASD, the better the outcome for the child,” said the study’s first author, Karen Pierce, PhD, professor of neurosciences and co-director of the UC San Diego Autism Center of Excellence. She led the study with senior author Eric Courchesne, PhD, also a professor of neurosciences.

Multiple studies, including research conducted by Pierce, have found that simple parent checklists performed at the child’s first birthday can identify symptoms of ASD. And yet the mean age of ASD diagnoses in the United States, write the researchers, is “often years later, generally between ages three and four.”

Pierce said the lag between the first signs of ASD and diagnosis represents a missed opportunity, particularly given the accelerated pace of brain development in the first years of life.

“Synaptic density or connections between neurons in the prefrontal and temporal cortex, brain regions centrally involved in higher order social behavior, doubles between birth and one to two years in age,” said Pierce. “It’s conceivable that outcomes for children with autism could be improved if treatment occurred during this period of rapid brain growth, rather than after, which is more commonly the case.”

To conduct their study, Pierce and colleagues assessed 1,269 toddlers from the general population (441 ASD, 828 non-ASD) who received their first diagnostic evaluation between 12 and 36 months and at least one subsequent evaluation, all by licensed psychologists. Diagnoses ranged from ASD and features of ASD to language and developmental delay or other developmental issues.

The overall diagnostic stability for ASD was 0.84, higher than for any other diagnostic group. Only 2 percent of toddlers initially considered to have ASD transitioned to later diagnoses of typical development. Within the group diagnosed with ASD, the most common transition was from ASD to ASD features at 9 percent.

Diagnostic stability of ASD was weakest at 12 to 13 months, just 0.50, but increased to 0.79 by 14 months and 0.83 by 16 months. Twenty-four percent of toddlers were not designated as ASD at their first evaluations, but later identified. The most common transition in this group was an initial designation of developmental delay (25 percent) or language delay (16 percent), transitioning to later-onset ASD.

“Our findings suggest that an ASD diagnosis becomes stable starting at 14 months, and overall is more stable than other diagnoses, such as language or developmental delay,” said Pierce.

“Once a toddler is identified as ASD, there is an extremely low chance that he or she will test within typical levels at age three or four, so it’s imperative that we use every effective tool as early as we can to begin treating diagnosed children to the benefit of them and their families over the long-term.”

Co-authors of this study also include: Vahid Gazestani, Elizabeth Bacon, Cynthia Carter Barnes, Debra Cha, Srinivasa Nalabolu, Linda Lopez, Adrienne Moore, Sunny Pence-Stophaeros, all at UC San Diego.

This research was funded, in part, by the National Institute of Mental Health, part of the National Institutes of Health (grants R01-MH104446, R01-MH080134, P50-MH081755).




Media Contact

Scott LaFee
858-249-0456
slafee@ucsd.edu

Share This Article


Related News

4/26/2018
Researchers at University of California San Diego School of Medicine are preparing a first-of-its-kind, multidisciplinary investigation to determine if and how cannabidiol, a non-psychoactive compound ...
10/18/2017
Modeling the interplay between neurons and astrocytes derived from children with Autism Spectrum Disorder (ASD), researchers at University of California San Diego School of Medicine, with colleagues i ...
7/13/2016
The majority of cases of autism spectrum disorder (ASD) are unknown. In a paper published in the journal Molecular Psychiatry, researchers at the University of California San Diego School of Medicine, ...
3/9/2015
In a study published in the current online issue of JAMA Psychiatry, an international team of scientists, led by researchers at the University of California, San Diego School of Medicine, report findi ...



Follow Us